Annual Total Assets
$28.20 M
+$6.92 M+32.49%
31 December 2023
Summary:
Galectin Therapeutics annual total assets is currently $28.20 million, with the most recent change of +$6.92 million (+32.49%) on 31 December 2023. During the last 3 years, it has fallen by -$1.40 million (-4.73%). GALT annual total assets is now -41.82% below its all-time high of $48.47 million, reached on 31 December 2019.GALT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$28.97 M
+$1.32 M+4.76%
30 September 2024
Summary:
Galectin Therapeutics quarterly total assets is currently $28.97 million, with the most recent change of +$1.32 million (+4.76%) on 30 September 2024. Over the past year, it has increased by +$6.81 million (+30.72%). GALT quarterly total assets is now -45.35% below its all-time high of $53.01 million, reached on 30 June 2019.GALT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.5% | +30.7% |
| 3 y3 years | -4.7% | -23.8% |
| 5 y5 years | +213.1% | -42.9% |
GALT Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.6% | +32.5% | -30.7% | +61.7% |
| 5 y | 5 years | -41.8% | +213.1% | -42.9% | +61.7% |
| alltime | all time | -41.8% | +6367.9% | -45.4% | +9399.0% |
Galectin Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.97 M(+4.8%) |
| June 2024 | - | $27.66 M(+6.8%) |
| Mar 2024 | - | $25.89 M(-8.2%) |
| Dec 2023 | $28.20 M(+32.5%) | $28.20 M(+27.2%) |
| Sept 2023 | - | $22.16 M(+10.4%) |
| June 2023 | - | $20.08 M(-0.7%) |
| Mar 2023 | - | $20.23 M(-5.0%) |
| Dec 2022 | $21.29 M(-49.1%) | $21.29 M(+18.8%) |
| Sept 2022 | - | $17.91 M(-30.8%) |
| June 2022 | - | $25.89 M(-23.0%) |
| Mar 2022 | - | $33.62 M(-19.6%) |
| Dec 2021 | $41.83 M(+41.3%) | $41.83 M(+10.0%) |
| Sept 2021 | - | $38.04 M(+13.9%) |
| June 2021 | - | $33.41 M(+45.9%) |
| Mar 2021 | - | $22.90 M(-22.6%) |
| Dec 2020 | $29.60 M(-38.9%) | $29.60 M(-13.1%) |
| Sept 2020 | - | $34.05 M(-17.6%) |
| June 2020 | - | $41.32 M(-6.3%) |
| Mar 2020 | - | $44.11 M(-9.0%) |
| Dec 2019 | $48.47 M(+438.2%) | $48.47 M(-4.5%) |
| Sept 2019 | - | $50.76 M(-4.2%) |
| June 2019 | - | $53.01 M(+577.0%) |
| Mar 2019 | - | $7.83 M(-13.1%) |
| Dec 2018 | $9.01 M(+116.4%) | $9.01 M(-15.2%) |
| Sept 2018 | - | $10.62 M(-5.3%) |
| June 2018 | - | $11.21 M(+127.3%) |
| Mar 2018 | - | $4.93 M(+18.5%) |
| Dec 2017 | $4.16 M(-73.7%) | $4.16 M(-40.7%) |
| Sept 2017 | - | $7.01 M(-24.8%) |
| June 2017 | - | $9.33 M(-33.4%) |
| Mar 2017 | - | $14.00 M(-11.4%) |
| Dec 2016 | $15.79 M(-40.2%) | $15.79 M(-2.0%) |
| Sept 2016 | - | $16.11 M(-11.7%) |
| June 2016 | - | $18.25 M(-19.9%) |
| Mar 2016 | - | $22.79 M(-13.7%) |
| Dec 2015 | $26.41 M(-11.0%) | $26.41 M(+22.8%) |
| Sept 2015 | - | $21.51 M(-19.4%) |
| June 2015 | - | $26.68 M(-11.0%) |
| Mar 2015 | - | $29.97 M(+1.0%) |
| Dec 2014 | $29.68 M(+177.0%) | $29.68 M(-5.2%) |
| Sept 2014 | - | $31.32 M(-9.5%) |
| June 2014 | - | $34.59 M(-6.2%) |
| Mar 2014 | - | $36.90 M(+244.4%) |
| Dec 2013 | $10.71 M(+12.0%) | $10.71 M(+9.6%) |
| Sept 2013 | - | $9.78 M(+87.1%) |
| June 2013 | - | $5.22 M(-27.4%) |
| Mar 2013 | - | $7.20 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $9.56 M(+44.6%) | $9.56 M(-14.6%) |
| Sept 2012 | - | $11.19 M(-16.0%) |
| June 2012 | - | $13.32 M(-14.3%) |
| Mar 2012 | - | $15.54 M(+135.0%) |
| Dec 2011 | $6.61 M(+5.0%) | $6.61 M(-18.4%) |
| Sept 2011 | - | $8.10 M(-0.7%) |
| June 2011 | - | $8.16 M(+14.5%) |
| Mar 2011 | - | $7.12 M(+13.1%) |
| Dec 2010 | $6.30 M(+1345.0%) | $6.30 M(+111.1%) |
| Sept 2010 | - | $2.98 M(-2.3%) |
| June 2010 | - | $3.05 M(+901.3%) |
| Mar 2010 | - | $305.00 K(-30.0%) |
| Dec 2009 | $436.00 K(-38.1%) | $436.00 K(-46.5%) |
| Sept 2009 | - | $815.00 K(-40.2%) |
| June 2009 | - | $1.36 M(+10.1%) |
| Mar 2009 | - | $1.24 M(+76.0%) |
| Dec 2008 | $704.00 K(-60.5%) | $704.00 K(-42.9%) |
| Sept 2008 | - | $1.23 M(-38.9%) |
| June 2008 | - | $2.02 M(-47.4%) |
| Mar 2008 | - | $3.84 M(+115.3%) |
| Dec 2007 | $1.78 M(-72.0%) | $1.78 M(+5.9%) |
| Sept 2007 | - | $1.68 M(-43.5%) |
| June 2007 | - | $2.98 M(-39.4%) |
| Mar 2007 | - | $4.92 M(-22.8%) |
| Dec 2006 | $6.36 M(+28.2%) | $6.36 M(-26.5%) |
| Sept 2006 | - | $8.66 M(-15.8%) |
| June 2006 | - | $10.29 M(-16.9%) |
| Mar 2006 | - | $12.38 M(+149.5%) |
| Dec 2005 | $4.96 M(-55.3%) | $4.96 M(-24.2%) |
| Sept 2005 | - | $6.55 M(-17.0%) |
| June 2005 | - | $7.89 M(-17.2%) |
| Mar 2005 | - | $9.53 M(-14.2%) |
| Dec 2004 | $11.11 M(+38.8%) | $11.11 M(-13.4%) |
| Sept 2004 | - | $12.83 M(+39.9%) |
| June 2004 | - | $9.17 M(+31.3%) |
| Mar 2004 | - | $6.98 M(-12.7%) |
| Dec 2003 | $8.00 M(+250.5%) | $8.00 M(+55.3%) |
| Sept 2003 | - | $5.15 M(+133.4%) |
| June 2003 | - | $2.21 M(-14.0%) |
| Mar 2003 | - | $2.57 M(+12.4%) |
| Dec 2002 | $2.28 M(+29.2%) | $2.28 M(+43.0%) |
| Sept 2002 | - | $1.60 M(+38.2%) |
| June 2002 | - | $1.16 M(-10.8%) |
| Mar 2002 | - | $1.30 M(-26.6%) |
| Dec 2001 | $1.77 M | $1.77 M(+50.9%) |
| Sept 2001 | - | $1.17 M(+25.4%) |
| June 2001 | - | $933.50 K |
FAQ
- What is Galectin Therapeutics annual total assets?
- What is the all time high annual total assets for Galectin Therapeutics?
- What is Galectin Therapeutics annual total assets year-on-year change?
- What is Galectin Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly total assets year-on-year change?
What is Galectin Therapeutics annual total assets?
The current annual total assets of GALT is $28.20 M
What is the all time high annual total assets for Galectin Therapeutics?
Galectin Therapeutics all-time high annual total assets is $48.47 M
What is Galectin Therapeutics annual total assets year-on-year change?
Over the past year, GALT annual total assets has changed by +$6.92 M (+32.49%)
What is Galectin Therapeutics quarterly total assets?
The current quarterly total assets of GALT is $28.97 M
What is the all time high quarterly total assets for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly total assets is $53.01 M
What is Galectin Therapeutics quarterly total assets year-on-year change?
Over the past year, GALT quarterly total assets has changed by +$6.81 M (+30.72%)